Publicacións nas que colabora con Luis Miguel Antón Aparicio (18)

2015

  1. Células madre y cáncer de colon

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 425-438

  2. Vías de señalización en cáncer de colon

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 439-452

2012

  1. Searching for Hif1-α interacting proteins in renal cell carcinoma

    Clinical and Translational Oncology, Vol. 14, Núm. 9, pp. 698-708

  2. Starvation profile of mTOR inhibitors

    Rapamycin: Effectiveness, Safety and Drug Interactions (Nova Science Publishers, Inc.), pp. 31-52

2011

  1. Expression of notch1 to -4 and their ligands in renal cell carcinoma: A tissue microarray study

    Cancer Genomics and Proteomics, Vol. 8, Núm. 2, pp. 93-101

  2. Fructose transporter GLUT5 expression in clear renal cell carcinoma

    Oncology Reports, Vol. 25, Núm. 2, pp. 315-323

  3. Molecular basis of hypertension side effects induced by sunitinib

    Anti-Cancer Drugs, Vol. 22, Núm. 1, pp. 1-8

  4. New insights into molecular mechanisms of sunitinib-associated side effects

    Molecular Cancer Therapeutics, Vol. 10, Núm. 12, pp. 2215-2223

  5. Relevant networks involving the p53 signalling pathway in renal cell carcinoma

    International Journal of Biomedical Science, Vol. 7, Núm. 4

  6. Stem cell and lung cancer development: Blaming the Wnt, Hh and notch signalling pathway

    Clinical and Translational Oncology, Vol. 13, Núm. 2, pp. 77-83

  7. Tissue array analysis for the differentiation of gliosis from gliomas

    Molecular Medicine Reports, Vol. 4, Núm. 3, pp. 451-457

2009

  1. Expression of Wnt gene family and frizzled receptors in head and neck squamous cell carcinomas

    Virchows Archiv, Vol. 455, Núm. 1, pp. 67-75

2008

  1. Diagnosis value of EGFR gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS

  2. Effectiveness of COX2 inhibitor treatment in patients with dysplastic oral leukoplakia

    EJC SUPPLEMENTS

  3. Utility of p53 gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS

2007

  1. Cyclooxygenase-2 (COX-2): A molecular target in prostate cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 11, pp. 694-702

  2. Prostate cancer and Hedgehog signalling pathway

    Clinical and Translational Oncology, Vol. 9, Núm. 7, pp. 420-428

  3. Prostate carcinoma and stem cells

    Clinical and Translational Oncology, Vol. 9, Núm. 2, pp. 66-76